The White House has withdrawn Heidi Overton's nomination to head the FDA, citing insufficient congressional support. Overton, nominated by Trump in August, faced opposition from Democrats and skepticism from some Republicans, particularly regarding her stance on childhood vaccine recommendations. The Senate Health Committee was set to vote on her nomination shortly. Since May, the FDA has been led by acting Commissioner Kyle Diamantas.
Key facts
- Heidi Overton's FDA nomination was withdrawn due to lack of support.
- Overton was nominated by Trump in August 2026.
- Senator Bill Cassidy expressed concerns over Overton's vaccine recommendations.
- The HELP committee was scheduled to vote on Overton's nomination.
- Kyle Diamantas has been acting FDA Commissioner since May.
A short AI summary in our own words. The reporting belongs to Axios; we don't reproduce it.